The Patent Finder

Aop Orphan Pharmaceuticals AG

Also on record
Records under this name other than the patents Aop Orphan Pharmaceuticals AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 5 of 5 · Back to Aop Orphan Pharmaceuticals AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,329,254Process for the Preparation of 6-Chloro-2,3,4,9-Tetrahydro-1H-CARBAZOLE-1-Carboxamide and Intermediates Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,213,464Method for Enhancing Engraftment of Haematopoetic Stem Cells
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,940,136Cannabinoids for prophylactic treatment of involuntary weight loss
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,486,990SirT inhibitors that bind to NAD
Formerly held
Term ended
Term ended Nov 20, 2024 · USPTO record
Term endedTerm ended Nov 20, 2024USPTO record
US 9,782,413Composition for treatment of essential thrombocythemia
Lapsed on the fee record
Ended Oct 10, 2021 · USPTO record
Lapsed on the fee recordEnded Oct 10, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited